Conditions Treated
Research Areas
Programs & Services
Education & Training
Education
- 1987
- Catholic University of America (Washington, DC), BEE
- 1982 - 1986
- Georgetown University (Washington DC), BS, Physics
- 1987 - 1991
- Georgetown University School of Medicine (Washington, DC), MD
Residency
- 1992 - 1994
- Eisenhower Army Medical Center (Fort Gordon, GA), Internal Medicine
- 1994 - 1996
- Fitzsimons AMC/National Jewish Health (Denver, CO), Allergy & Immunology
- 1996 - 1997
- Walter Reed Army Medical Center (Washington, DC), Clinical Laboratory Immunology
Special Interests
Research Interests
Asthma airway inflammation and biomarkers.
Board Certification
1997, 2007: American Board of Allergy & Immunology
1997: Specialty Certification in Clinical Laboratory Immunology
1994, 2004: American Board of Internal Medicine
1989, 1991, 1992: National Board of Medical Examiners, Parts I, II, III
Professional Memberships
1994-Present: American Academy of Allergy, Asthma, and Immunology, Fellow (FAAAAI)
1994-Present: American College of Allergy, Asthma and Immunology, Fellow (FACAAI)
1991-Present: American College of Physicians, Fellow (FACP)
1997-Present: Clinical Immunology Society
Publications
Orange JS, Ballow M, Stiehm ER, Ballas ZK, Chinen J, De La Morena M, Kumararatne D, Harville TO, Hesterberg P, Koleilat M, McGhee S, Perez EE, Raasch J, Scherzer R, Schroeder H, Seroogy C, Huissoon A, Sorensen RU, Katial R. Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2012 Sep;130(3 Suppl):S1-S24.
Hoyte FC, Weber RW, Katial RK. Pancreatitis as a novel complication of aspirin therapy in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2012 Jun;129(6):1684-6.
Mudd PA, Katial RK, Alam R, Hohensee S, Ramakrishnan V, Kingdom TT. Variations in expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with nasal polyposis. Ann Allergy Asthma Immunol. 2011 Oct;107(4):353-9.
Katial R, Bernstein D, Prazma C, Lincourt W, Stempel D. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone. Allergy Asthma Proc. 2011 Mar;32(2):127-36.
More Publications by This Author
Link to Faculty Publications
Link to PubMed for more papers
Teaching or Professional Positions
Present: Program Director, Allergy and Clinical Immunology Fellowship Program UCD– Adult Program
Present: Director, Weinberg Clinical Research Unit
Present: Director, Allergy and Immunology Clinical Services
Present: Chair, Vaccine and Therapuetics Committee, American Academy of Allergy, Asthma & Immunology
2005-2008: Vice President of the Colorado Allergy Society
1998-2008: Program Director, Diagnostic Laboratory Immunology, Walter Reed Army Medical Center
Awards & Recognition
9/2012: Castle Connolly Top Doctors
8/2012: Selected to the Top Doctors by 5280: Denver’s Magazine
8/2012: 2012 US News and World Report Top Doctor Award for Allergy and Immunology
9/2011: Castle Connolly Top Doctors
9/2011: Elected to Best Doctors in America® 2011-2012 database.
8/2011: 2011 US News and World Report Top Doctor Award for Allergy and Immunology
5/2011: Elected to The Academy of Medical Educators at the University of Colorado Denver
10/2010: Finalist Parker J. Palmer “Courage to Teach” Award for Program Director
10/2010: Excellence, Accreditation Council for Graduate Medical Education
6/2010: Outstanding Teacher of the Year, Pediatric Fellowship Program, National Jewish Health
Affiliations with the University of Colorado Denver
Professor of Medicine, National Jewish Health and University of Colorado Denver
Program Director of the Allergy and Clinical Immunology Fellowship Program UCD– Adult Program
Conflict of Interest
National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict
conflict of interest policy
to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry
relationships and collaborations.